Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Fusen Pharmaceutical Company Limited 1652.HK
$1.37
На 18:03, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
1014843600.00000000
-
week52high
2.10
-
week52low
0.89
-
Revenue
491757000
-
P/E TTM
55
-
Beta
0.30549400
-
EPS
-0.06000000
-
Last Dividend
0.01000000
-
Next Earnings Date
28 мар 2023 г. в 14:42
Описание компании
Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China. The company's product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; and flunarizine hydrochloride capsules and compound ferrous sulfate granules, as well as Yuanhu Zhitong oral solutions, Ganweikang tablets, and Yixinkang tablets. In addition, it researches, develops, produces, and sells various proprietary Chinese medicines and western medicine products for the treatment of cold and fever, cardiovascular diseases, and anemia. Further, the company offers business management and consulting services. Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии